Since the first sequencing of the human genome in 2003, tremendous gains have been made in understanding hereditary cancer syndromes, with over 50 having been identified. Non-invasive tests to assess a person’s inherited risk of developing certain cancers are abundant. However, genetic tests to diagnose cancer have been much more difficult to develop. By unlocking the hidden genome, Orbit Genomics is taking precision medicine one step further in developing cancer diagnostics.

For more information (animation)

About Us

Orbit GenomicsOrbit Genomics was founded to develop microsatellite based diagnostics and services which assist in treatment decisions to significantly improve patient outcomes.


Orbit GenomicsOrbit Genomics’ analysis of the hidden genome is accelerating precision medicine by developing clinically actionable diagnostics and services.

Contact Us

Orbit GenomicsFor more information on our products or to receive copies of publications, please contact us.